KDR and neoplasm: Seemingly, reducing protumorigenic TAMs and inhibiting VEGFR2 signaling, which not only blocks angiogenesis but also affects other immune cells such as regulatory and cytotoxic T cells, are insufficient to eliminate the tumor.